Cargando…
Metformin in COVID-19: clinical trials are needed to prove its benefits
Autores principales: | Kow, Chia Siang, Ramachandram, Dinesh Sangarran, Hasan, Syed Shahzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8741591/ https://www.ncbi.nlm.nih.gov/pubmed/34997410 http://dx.doi.org/10.1007/s11845-021-02869-9 |
Ejemplares similares
-
Use of sulforaphane in COVID-19: Clinical trials are needed
por: Kow, Chia Siang, et al.
Publicado: (2022) -
Metformin therapy in COVID-19: inhibition of NETosis
por: Kow, Chia Siang, et al.
Publicado: (2022) -
Use of aspirin for primary prevention in patients with diabetes during the COVID-19 pandemic
por: Kow, Chia Siang, et al.
Publicado: (2021) -
Colchicine for COVID-19: Hype or hope?
por: Kow, Chia Siang, et al.
Publicado: (2022) -
Insulin therapy in patients with COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)